Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Executive Vice President & CFO
-
Issuer Symbol
-
AMRX on Nasdaq
Tasos Konidaris - trading volume in the past year for Amneal Pharmaceuticals, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Performance-Based Restricted Stock Units |
228,310 |
$2,018,260 |
$8.84 |
03 Mar 2025 |
Direct |
Class A Common Stock |
|
| Restricted Stock Units |
131,945 |
$1,166,394 |
$8.84 |
04 Mar 2025 |
Direct |
Class A Common Stock |
|
| Class A Common Stock |
122,152 |
$1,151,893 |
$9.43 |
15 Aug 2025 |
Direct |
|
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.